UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 65,308 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 13.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 551,442 shares of the medical instruments supplier's stock after purchasing an additional 65,308 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.28% of DENTSPLY SIRONA worth $10,466,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Colonial Trust Co SC bought a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at about $26,000. Riverview Trust Co bought a new stake in DENTSPLY SIRONA in the 4th quarter valued at approximately $26,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in DENTSPLY SIRONA by 700.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after acquiring an additional 1,568 shares in the last quarter. True Wealth Design LLC lifted its stake in DENTSPLY SIRONA by 866.7% in the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock valued at $41,000 after acquiring an additional 1,950 shares in the last quarter. Finally, Quarry LP lifted its stake in DENTSPLY SIRONA by 25.7% in the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after acquiring an additional 780 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Price Performance

Shares of XRAY traded down $0.36 during trading hours on Monday, hitting $15.62. 1,999,347 shares of the company were exchanged, compared to its average volume of 2,962,926. The company has a market cap of $3.11 billion, a price-to-earnings ratio of -7.55, a P/E/G ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $28.25. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The firm's fifty day moving average is $14.52 and its 200 day moving average is $17.03.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.14. The company had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA's quarterly revenue was down 7.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.42 EPS. On average, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.64 annualized dividend and a dividend yield of 4.10%. DENTSPLY SIRONA's dividend payout ratio is currently -14.10%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on XRAY shares. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Barrington Research boosted their price target on DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an "outperform" rating in a research report on Monday, May 12th. Wells Fargo & Company lowered their price target on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. UBS Group lowered their price target on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Friday, May 9th. Finally, Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Eleven analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of "Hold" and a consensus price target of $20.36.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.